Understanding How Blood Stem Cells Age and Stay Healthy
Translation Fidelity in Hematopoietic Stem Cell Aging and Longevity
This project explores how blood stem cells maintain their quality as we get older, which could help prevent age-related blood disorders and cancers.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11132638 on NIH RePORTER |
What this research studies
As we age, our blood stem cells can become less effective, leading to problems like immune issues, anemia, and a higher risk of cancer. This work looks at how these stem cells make proteins and whether mistakes in this process contribute to aging. We want to see if improving the accuracy of protein production can help keep blood stem cells healthy and working well for longer. This could lead to new ways to boost the health and lifespan of these important cells, potentially preventing age-related blood disorders.
Who could benefit from this research
Good fit: Patients who might benefit from future applications of this research include older adults experiencing age-related immune dysfunction, anemia, bone marrow failure, or those at risk for clonal hematopoiesis and certain blood cancers.
Not a fit: Patients whose conditions are unrelated to hematopoietic stem cell aging or protein synthesis fidelity may not directly benefit from this specific line of research.
Why it matters
Potential benefit: If successful, this work could lead to new treatments to improve blood stem cell health, potentially preventing or treating age-related blood disorders, immune dysfunction, and certain cancers.
How similar studies have performed: This research explores a novel aspect of translation fidelity in a cell-type and age-specific manner in vivo, with no previously reported interventions specifically boosting translation fidelity in mammals.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Signer, Robert A.j. — University of California, San Diego
- Study coordinator: Signer, Robert A.j.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.